Related Experiment Videos

Phase 2 study of high dose etoposide (VP16-213) in hepatocellular carcinoma

W Shiu, S D Mok, N Leung

Japanese Journal of Clinical Oncology

|June 1, 1987

Abstract:

A phase II study of etoposide (VP16-213) in hepatocellular carcinoma was conducted among 18 Chinese patients. There was no observable tumour response but the treatment was relatively well tolerated with an overall median survival interval of 74 days.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

[Studies on the role of chromobox protein homolog 2 in the inhibition of progression of hepatoma].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2019

[Development status of biliary tract imaging technology].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2019

Functional characterization of ultraspiracle in Leptinotarsa decemlineata using RNA interference assay.

Insect molecular biology·2019

Polymorphisms of the prolactin gene and their association with egg production traits in two Chinese domestic ducks.

British poultry science·2019

[Epidemic characteristics of adult Barton's fractures between Western and Eastern of China from 2010 to 2011].

Zhonghua yi xue za zhi·2019

Polychromatic emission in a wide energy range from InP-InAs-InP multi-shell nanowires.

Nanotechnology·2019

See all related articles